Prof. Benjamin Besse is the Director of Clinical Research at the Gustave Roussy Institute and is Professor of Medical Oncology at Paris-Saclay University, France.

His research interests focus on the application of personalised therapeutic strategies based on molecular abnormalities, circulating biomarkers and early drug development in thymic malignancies and thoracic tumours. Prof. Besse has authored and co-authored over 400 peer-reviewed articles; and is a part since 2020 of the Highly Cited Researchers list of Clarivate.

Previously, Prof. Besse was Chair of the ESMO Consensus Conference on Lung Cancer published in Annals of Oncology and has served as Principal Investigator for over 30 phase I/II clinical trials. Prof. Besse was elected Chair of the European Organisation for Research and Treatment of Cancer (EORTC) Lung Cancer Group from 2014 to 2020 and is currently Chair of the EORTC Scientific Chairs Council. He coordinates the French Network for Thymic Malignancies (RYTHMIC). He is a member of several organisations including the American Society of Clinical Oncology (ASCO), International Association for the Study of Lung Cancer (IASLC), and European Society of Medical Oncology (ESMO). In recognition for his academic work on thoracic malignancies, Prof. Besse has received a Hubertus-Wald Award in 2022.